Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors

Department of Autoimmune Diseases, School of Medicine, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.
Rheumatology (Impact Factor: 4.44). 09/2007; 46(8):1359-62. DOI: 10.1093/rheumatology/kem079
Source: PubMed

ABSTRACT To identify features present at diagnosis that were prospectively associated with adverse outcomes in a large cohort of patients with primary Sjögren's syndrome (SS).
Two hundred and sixty-six patients diagnosed with primary SS in our department between 1984 and 2002 were consecutively included and followed up. Outcomes measured were vasculitis, B-cell lymphoma and death. Cox regression analysis was used to evaluate the effect of variables at diagnosis on outcomes.
Twenty-five (9%) patients developed vasculitis. Multivariate analysis identified parotid scintigraphy grades III or IV (HR 3.55, P = 0.05) and C4 levels <0.11 g/l (HR 8.26, P < 0.001) as variables predicting the development of vasculitis. Nine (3%) patients developed B-cell lymphoma. Multivariate analysis identified C3 levels <0.82 g/l (HR 7.54, P = 0.016) as a predictive factor of lymphoma development. Twenty-five (9%) patients died during follow-up. Systemic involvement (HR 4.51, P = 0.022), vasculitis (HR 4.58, P = 0.042), C4 levels <0.11 g/l (HR 5.47, P = 0.027) and cryoglobulins (HR 4.58, P = 0.013) were independently associated with death. The presence of at least two of the above-mentioned predictive factors (parotid scintigraphy, vasculitis, hypocomplementaemia and cryoglobulinaemia) was associated with a lower survival in comparison with patients with no factor (log rank and Breslow tests <0.001).
The main prognostic factors for an adverse outcome identified in our cohort of patients with primary SS were vasculitis, severe involvement in parotid scintigraphy, hypocomplementaemia and/or cryoglobulins at diagnosis. Patients with at least two of these factors need a closer follow-up.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sjögren's syndrome (SS) is a complex autoimmune exocrinopathy with multifactorial pathogenesis and multisystem manifestation. It is called primary Sjögren's syndrome (PSS) when the manifestations are seen without any other co-existent rheumatic diseases. The incidence of respiratory system involvement varies widely in the reported medical literature, partly due to lack of a universal agreement over the diagnostic criteria of the disease and the type of study methods employed. Respiratory system manifestations are protean; upper airway symptoms are very common and so is the complaint of dry cough. The PSS patients may develop interstitial lung diseases (ILDs) such as usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonia (LIP), bronchiolitis obliterans and organising pneumonia (BOOP), etc. They may also develop the whole spectrum of lymphoproliferative disorders of the lung ranging from LIP to follicular bronchiolitis, nodular lymphoid hyperplasia and low-grade lymphomas. Therapeutic options include symptomatic and supportive measures and corticosteroids as the mainstay of the treatment for ILDs occurring in these patients. In recent years, rituximab (anti-CD20) has emerged as a promising treatment for this disease, though data from controlled trials are still lacking. Pulmonary involvement may be a source of significant morbidity in these patients, though only rarely, it is the cause of death.
    The Indian journal of chest diseases & allied sciences 51(2):93-101.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Das nach den AECG-Kriterien diagnostizierte primäre Sjögren-Syndrom (pSS) ist mit einer Prävalenz von rund 0,2% in der erwachsenen Normalbevölkerung und einer Jahresinzidenz von 4/100.000 Gesamtbevölkerung deutlich seltener als bisher angenommen. Auch der wiederkehrend berichtete Anteil von einem Mann auf 9Frauen dürfte eher bei etwa 1:20 liegen. An pSS erkrankte Männer haben seltener immunologische, histopathologische oder sialographische Befunde und Organbeteiligungen. Das Erkrankungsalter liegt in jüngeren Untersuchungen mit rund 45Jahren um rund 10Jahre niedriger als in solchen des letzten Jahrzehnts. Im jüngeren Alter erkrankte Patienten sind häufiger Rheumafaktor- und/oder Anti-Ro/SS-A-positiv und leiden häufiger an Hypokomplementämie oder Lymphadenopathien. Mit der Einführung der spezifischeren AECG-Kriterien finden sich weniger Männer, mehr jüngere und mehr schwer erkrankte Patienten in pSS-Kohorten. Etwa 5–10% der pSS-Patienten spezialisierter Zentren leiden an schwerwiegenden extraglandulären Manifestationen. Diese zeigen sich zumeist früh im Krankheitsverlauf und gehen z.T. mit erhöhter Mortalität einher. Betroffene ohne früh auftretende Organbeteiligungen können mehrheitlich mit einem leichten bis mäßig schweren Verlauf rechnen. In Deutschland wird nur rund ein Zehntel der Sjögren-Kranken rheumatologisch betreut. Zusammen mit den nach AECG-Kriterien nicht berücksichtigten Anti-Ro/La-negativen Sjögren-Kranken und den Patienten mit sekundärem Sjögren-Syndrom dürften mindestens 0,4% der erwachsenen Bevölkerung unter stark beeinträchtigender immunpathologischer Sicca-Symptomatik leiden. According to the classification criteria of the American-European Consensus Group (AECG), the prevalence of primary Sjögren’s syndrome (pSS) of about 0.2% in the adult population and a yearly incidence of 4/100.000 in the general population are far lower than previously assumed. Moreover, the repeatedly reported male/female ratio of 1:9 seems to lie more in the range of 1:20. Male pSS patients show fewer immunological, histopathological or sialographic findings and organ involvement. Information on age at disease onset has also changed over the last decade. Recent studies indicate an onset age of approximately 45 years as compared to 56 in earlier studies of the last decade. Patients with an early disease onset are more frequently positive for rheumatoid factor (RF) and/or anti-Ro/SS-A. These patients also seem to have a higher risk of developing hypocomplementemia or lymphadenopathy. As compared to earlier cohorts, the introduction of the rather specific AECG criteria will probably result in the participation of fewer men, younger patients in general and of more seriously ill patients in future cohorts. The change in the spectrum of pSS patients obviously reflects the altered classification criteria since the AECG criteria require anti-Ro/La positivity and therefore exclude a high number of patients with other immunological markers who also show severe sicca symptoms and organ involvements. About 5%–10% of pSS patients in rheumatological care suffer from severe extraglandular manifestations, which generally occur soon after disease onset. In particular, palpable purpura, hypocomplementemia, cryoglobulinemia and lymphoma are associated with increased mortality. In Germany, approximately one tenth of Sjögren syndrome patients receive specialized rheumatological care. There is still insufficient knowledge about the vast majority of pSS patients who are not treated by rheumatologists. These patients, as well as all those who, according to the AECG criteria, are not classified as having pSS either due to anti-Ro/La negativity or having secondary Sjögren’s syndrome, probably add up to at least 0.4% of the adult population which, at present, suffers from considerable immunopathologic sicca symptoms.
    Zeitschrift für Rheumatologie 02/2009; 69(1):41-49. DOI:10.1007/s00393-009-0518-3 · 0.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper is concerned with speech training systems which intend to show how to articulate vowels and some consonants displaying vocal tract shapes. The first one is implemented on a microcomputer and relates to articulation of vowels. It shows whether the uttered vowel is more similar to the intended vowel than to each of the other vowels, and instructs how to articulate the vowel by displaying both the reference lateral vocal tract shape and the one presumed from the uttered voice. It can adapt its performance automatically to the child's progress pace in learning. It can be used as a discriminator of words, and is also suitable for self-teaching. The other system estimates the vocal tract shapes of vowels and of some stop and fricative consonants from uttered speech waves, and instructs how to articulate. For the articulation of vowels, the system points out defects about the place of articulation and opening of lips, and for the articulation of consonants, it points out the defect about the place of articulation and displays how to correct the articulation.
    Acoustics, Speech, and Signal Processing, IEEE International Conference on ICASSP '86.; 05/1986